Generation Bio Co.
GBIO
$5.23
$0.122.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 108.37% | -91.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 108.37% | -91.23% | |||
| Cost of Revenue | 32.73% | 2.50% | |||
| Gross Profit | -27.60% | -272.97% | |||
| SG&A Expenses | 60.07% | -10.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 45.86% | -4.23% | |||
| Operating Income | -43.73% | -44.83% | |||
| Income Before Tax | 73.62% | -41.35% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 73.62% | -41.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 73.62% | -41.35% | |||
| EBIT | -43.73% | -44.83% | |||
| EBITDA | -44.79% | -48.40% | |||
| EPS Basic | 73.74% | -41.28% | |||
| Normalized Basic EPS | -51.22% | -49.29% | |||
| EPS Diluted | 73.74% | -41.28% | |||
| Normalized Diluted EPS | -51.22% | -49.29% | |||
| Average Basic Shares Outstanding | 0.48% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.48% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||